The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Open accessAbstract
OBJECTIVE: To describe the prevalence and determinants of hyperfiltration (glomerular filtration rate [GFR] ≥120 mL/min/1.73 m2), GFR decline, and nephropathy onset or progression in type 2 diabetic patients with normo- or microalbuminuria. RESEARCH DESIGN AND METHODS: We longitudinally studied 600 hypertensive type 2 diabetic patients with albuminuria <200 μg/min and who were retrieved from two randomized trials testing the renal effect of trandolapril and delapril. Target blood pressure (BP) was <120/80 mmHg, and HbA1c was <7%. GFR, albuminuria, and glucose disposal rate (GDR) were centrally measured by iohexol plasma clearance, nephelometry in three consecutive overnight urine collections, and hyperinsulinemic euglycemic clamp, respectively. RESULTS: Over a median (range) follow-up of 4.0 (1.7–8.1) years, GFR declined by 3.37 (5.71–1.31) mL/min/1.73 m2 per year. GFR change was bimodal over time: a larger reduction at 6 months significantly predicted slower subsequent decline (coefficient: −0.0054; SE: 0.0009), particularly among hyperfiltering patients. A total of 90 subjects (15%) were hyperfiltering at inclusion, and 11 of 47 (23.4%) patients with persistent hyperfiltration progressed to micro- or macroalbuminuria versus 53 (10.6%) of the 502 who had their hyperfiltration ameliorated at 6 months or were nonhyperfiltering since inclusion (hazard ratio 2.16 [95% CI 1.13–4.14]). Amelioration of hyperfiltration was independent of baseline characteristics or ACE inhibition. It was significantly associated with improved BP and metabolic control, amelioration of GDR, and slower long-term GFR decline on follow-up. CONCLUSIONS: Despite intensified treatment, patients with type 2 diabetes have a fast GFR decline. Hyperfiltration affects a subgroup of patients and may contribute to renal function loss and nephropathy onset or progression. Whether amelioration of hyperfiltration is renoprotective is worth investigating.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527
Regression to the mean: what it is and how to deal with it
Barnett, A. G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh299 · Cited by 1,988
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data
Cnaan, A., Laird, N. M., & Slasor, P. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971030)16:20<2349::aid-sim667>3.0.co;2-e · Cited by 1,222
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study
Rowe, J. W., Andres, R., Tobin, J. D., Norris, A. H., & Shock, N. W. (1976) · Journal of Gerontology · doi:10.1093/geronj/31.2.155 · Cited by 1,104
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
Self-citationParving, H.-H., Smidt, U., Andersen, A., & Svendsen, P. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92462-5 · Cited by 867
The modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J. J., Hunsicker, L. G., Schluchter, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Kramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618
Ruggenenti, P., Perna, A., Gherardi, G., Gaspari, F., Benini, R., & Remuzzi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04433-x · Cited by 574
Self-citationNelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.
Gaspari, F., Perico, N., Ruggenenti, P., Mosconi, L., Amuchastegui, C. S., Guerini, E., Daina, E., & Remuzzi, G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v62257 · Cited by 375
Self-citationMagee, G. M., Bilous, R. W., Cardwell, C. R., Hunter, S. J., Kee, F., & Fogarty, D. G. (2009) · Diabetologia · doi:10.1007/s00125-009-1268-0 · Cited by 345
Meta‐analysis of continuous outcome data from individual patients
Higgins, J. P. T., Whitehead, A., Turner, R. M., Omar, R. Z., & Thompson, S. G. (2001) · Statistics in Medicine · doi:10.1002/sim.918 · Cited by 265
Time to abandon microalbuminuria?
Ruggenenti, P., & Remuzzi, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001729 · Cited by 213
Self-citationThe clinical significance of hyperfiltration in diabetes
Jerums, G., Premaratne, E., Panagiotopoulos, S., & MacIsaac, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1794-9 · Cited by 198
Gaspari, F., Ferrari, S., Stucchi, N., Centemeri, E., Carrara, F., Pellegrino, M., Gherardi, G., Gotti, E., Segoloni, G., Salvadori, M., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00579.x · Cited by 192
Self-citationInsulin Resistance and Microalbuminuria
Parvanova, A. I., Trevisan, R., Iliev, I. P., Dimitrov, B. D., Vedovato, M., Tiengo, A., Remuzzi, G., & Ruggenenti, P. (2006) · Diabetes · doi:10.2337/db05-1484 · Cited by 189
Self-citationBash, L. D., Selvin, E., Steffes, M., Coresh, J., & Astor, B. C. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2440 · Cited by 186
Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.
Gaspari, F., Perico, N., Matalone, M., Signorini, O., Azzollini, N., Mister, M., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v92310 · Cited by 161
Self-citationThe multi‐faceted cross‐talk between the insulin and angiotensin II signaling systems
Velloso, L. A., Folli, F. B., Perego, L., & Saad, M. J. A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.611 · Cited by 114
Ruggenenti, P. L., Lauria, G., Iliev, I. P., Fassi, A., Parvanova, A. I., Rota, S., Chiurchiu, C. R., Barlovič, D. P., Sghirlanzoni, A., Lombardi, R., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.174474 · Cited by 104
Self-citationGassman, J., Greene, T., Wright, J. T., Agodoa, L. Y. C., Bakris, G. L., Beck, G. J., Douglas, J. G., Jamerson, K., Lewis, J. B., Kutner, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070080.21680.cb · Cited by 92
Early Renal Function Decline in Type 2 Diabetes
Pavkov, M. E., Knowler, W. C., Lemley, K. V., Mason, C. C., Myers, B. D., & Nelson, R. G. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07610711 · Cited by 88
Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study
Yip, J. W., Jones, S. L., Wiseman, M. J., Hill, C. E., & Viberti, G. C. (1996) · Diabetes · doi:10.2337/diab.45.12.1729 · Cited by 85
Moriya, T., Tsuchiya, A., Okizaki, S.-I., et al. (2011) · Kidney International · doi:10.1038/ki.2011.404 · Cited by 84
Andersen, S., Brøchner‐Mortensen, J., Parving, H., & Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3296 · Cited by 84
Hansen, H. P., Rossing, P. R., Tarnow, L., Nielsen, F. S., Jensen, B. R., & Parving, H. (1995) · Kidney International · doi:10.1038/ki.1995.238 · Cited by 82
Ruggenenti, P. L., Fassi, A., Parvanova, A. I., Iliev, I. P., Chiurchiu, C. R., Rubis, N., Gherardi, G., Ene‐Iordache, B., Gaspari, F., Perna, A., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834069bd · Cited by 79
Self-citationSilveiro, S. P., Friedman, R., de Azevedo, M. J., Canani, L. H. S., & Gross, J. L. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.171 · Cited by 76
Fontseré, N., Salinas, I., Bonal, J., Bayés, B., Riba, J., Torres, F., Ríos, J., Sanmartí, A., & Romero, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl221 · Cited by 74
Chaiken, R. L., Eckert‐Norton, M., Bard, M., Banerji, M. A., Palmisano, J. J., Sachimechi, I., & Lebovitz, H. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2129 · Cited by 55
How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
Chudleigh, R. A., Dunseath, G., Evans, W., Harvey, J. N., Evans, P., Ollerton, R., & Owens, D. R. (2007) · Diabetes Care · doi:10.2337/dc06-1688 · Cited by 49
The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics
The BENEDICT Group (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00028-x · Cited by 38
Thomaseth, K., Pacini, G., Morelli, P., Tonolo, G., & Nosadini, R. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.05.006 · Cited by 14
Cited by
Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Cherney, D. Z. I., Perkins, B. A., Soleymanlou, N., Maione, M., Lai, V., Lee, A., Fagan, N. M., Woerle, H. J., Johansen, O. E., Broedl, U. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005081 · Cited by 1,329
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
Update on the treatment of type 2 diabetes mellitus
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 589
Metadata
- Authors
- Ruggenenti, P., Porrini, E. L., Gaspari, F., Motterlini, N., Cannata, A., Carrara, F., Cella, C., Ferrari, S., Stucchi, N., Parvanova, A., Iliev, I., Dodesini, A. R., Trevisan, R., Bossi, A., Zaletel, J., Remuzzi, G., & for the GFR Study Investigators
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-09-11
- Volume
- 35
- Issue
- 10
- Pages
- 2061-2068
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2113285066
- Cited by
- 321
- References
- 38
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.